Evidence map›Paper›PMID 32231201›Full record

ArticleCell death & disease2020

Correction: Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K.

Giulia Petroni, Giacomo Bagni, Jessica Iorio, Claudia Duranti, Tiziano Lottini, Matteo Stefanini, Goran Kragol, Andrea Becchetti, Annarosa Arcangeli

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Giulia PetroniDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Giacomo BagniDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Jessica IorioDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Claudia DurantiDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Tiziano LottiniDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Matteo StefaniniDepartment of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy.
Goran KragolFidelta Ltd., Prilaz baruna Filipovića 29, 10000, Zagreb, Croatia.
Andrea Becchetti *Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milano, Italy.
Annarosa Arcangeli *Department of Experimental and Clinical Medicine, University of Firenze, Viale GB Morgagni 50, 50134, Firenze, Italy. annarosa.arcangeli@unifi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The financial support for this Article was not fully acknowledged. The acknowledgements should have included the following: We thank M. Lulli (University of Florence, Italy) for acquiring images of immunofluorescence-labeled cells. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (#15627, #21510 and #19766 to A.A.); PAR FAS-Linea di Azione 1.1-Azione 1.1.2-Bando FAS Salute. 2014 (DD 4042/ 2014) Project OMITERC to A.A.; FAR 2018 to A.B.

Identifiers

PMID32231201
PMCPMC7105481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.